Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Africa CDC’s support for the MOSA, a pan-African randomized platform ...

Press Release - Africa CDC's support for the MOSA, a pan-African randomized platform adaptive trial for the MpOx Study, adding to the initial EU funding, has enabled the enrollment of the first ...

( MENAFN - IANS) Kampala, Jan 17 (IANS) Uganda has received 2,000 doses of monkeypox vaccine from the Africa Centers for disease Control and Prevention (Africa CDC) for a prevention campaign to be ...

KAMPALA, Jan. 17 (Xinhua) -- Uganda has received 2,000 doses of mpox vaccine from the Africa Centers for Disease Control and Prevention (Africa CDC) for a prevention campaign to be launched next month ...

ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Africa CDC's support for the MOSA, a pan-African randomized platform ad ...

M ore than three years have passed since federal health officials arrived in central Appalachia to assess an alarming ...